Ethan Dmitrovsky, MD, Oral History Interview, July 7, 2015
Files
Download Full Interview Transcript (519 KB)
Loading...
Description
Major Topics Covered:
- Global Academic Programs and international partnerships
- Conflict of interest; ethics; social responsibility; institutional transparency
- Leadership philosophy
- MD Anderson mission and culture
- Cancer as a problem of humanity
Interview Chapters
Chapter 18: Global Academic Programs: a Review of International Collaboration
Chapter 19: Cancer is a Problem for All Humanity: A Truth that Inspires Faculty
Chapter 20: Addressing Perceived Conflict of Interest
Chapter 21: The Next Ten Years: Goals for MD Anderson Research and Faculty
Chapter 22: The Next Ten Years: Stewardship and Building A Culture of Care For Faculty and Staff
Identifier
DmitrovskyE_04_20150707
Publication Date
7-6-2015
Publisher
The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Dmitrovsky, Ethan MD and Rosolowski, Tacey A. PhD, "Ethan Dmitrovsky, MD, Oral History Interview, July 7, 2015" (2015). Interview Sessions. 104.
https://openworks.mdanderson.org/mchv_interviewsessions/104
Conditions Governing Access
Open
About the Interview
About the Interview Subject:
Ethan Dmitrovsky, MD came to MD Anderson in 2013 to serve as the institution’s Provost and Executive Vice President. He has a faculty appointment in the Department of Thoracic/Head and Neck Medical Oncology in the Division of Cancer Medicine.
Dr. Dmitrovsky’s translational research areas include: retinoid differentiation-based therapy for acute promyelocytic leukemia (APL); developed the molecular genetic test used to detect the PML/RARalpha transcript from the APL t(15;17) rearrangement; retinoid mechanisms leading to cell cycle arrest and repair of DNA damage in normal/malignant lung epithelial cells; engineered transgenic mouse models that express wild-type or proteasomal degradation-resistant cyclin E species in the lung; derived lung cancer cell lines leading to a new model to assess activity of lung cancer therapy and chemopreventive agents (antineoplastics).